372 related articles for article (PubMed ID: 30978462)
21. PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
Kang S; Jeong H; Baek JH; Lee SJ; Han SH; Cho HJ; Kim H; Hong HS; Kim YH; Yi EC; Seo SW; Na DL; Hwang D; Mook-Jung I
J Alzheimers Dis; 2016 Jul; 53(4):1563-76. PubMed ID: 27392853
[TBL] [Abstract][Full Text] [Related]
22. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH
J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793
[TBL] [Abstract][Full Text] [Related]
23. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
24. Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.
Bergland AK; Proitsi P; Kirsebom BE; Soennesyn H; Hye A; Larsen AI; Xu J; Legido-Quigley C; Rajendran L; Fladby T; Aarsland D
J Alzheimers Dis; 2020; 77(3):1117-1127. PubMed ID: 32804144
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.
Alexopoulos P; Gleixner LS; Werle L; Buhl F; Thierjung N; Giourou E; Kagerbauer SM; Gourzis P; Kübler H; Grimmer T; Yakushev I; Martin J; Kurz A; Perneczky R
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):519-524. PubMed ID: 28602012
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
Sriwichaiin S; Chattipakorn N; Chattipakorn SC
J Alzheimers Dis; 2021; 84(1):23-50. PubMed ID: 34511504
[TBL] [Abstract][Full Text] [Related]
27. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
[TBL] [Abstract][Full Text] [Related]
28. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
[TBL] [Abstract][Full Text] [Related]
29. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.
Gómez-Pascual A; Naccache T; Xu J; Hooshmand K; Wretlind A; Gabrielli M; Lombardo MT; Shi L; Buckley NJ; Tijms BM; Vos SJB; Ten Kate M; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleó A; Popp J; Martinez-Lage P; Streffer J; Barkhof F; Zetterberg H; Visser PJ; Lovestone S; Bertram L; Nevado-Holgado AJ; Gualerzi A; Picciolini S; Proitsi P; Verderio C; Botía JA; Legido-Quigley C
Comput Biol Med; 2024 Jun; 176():108588. PubMed ID: 38761503
[TBL] [Abstract][Full Text] [Related]
30. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
32. The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
Benussi L; Ghidoni R; Dal Piaz F; Binetti G; Di Iorio G; Abrescia P
J Alzheimers Dis; 2017; 56(2):825-833. PubMed ID: 27983556
[TBL] [Abstract][Full Text] [Related]
33. Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
Darst BF; Huo Z; Jonaitis EM; Koscik RL; Clark LR; Lu Q; Kremen WS; Franz CE; Rana B; Lyons MJ; Hogan KJ; Zhao J; Johnson SC; Engelman CD
J Alzheimers Dis; 2021; 79(3):1041-1054. PubMed ID: 33427733
[TBL] [Abstract][Full Text] [Related]
34. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
35. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
36. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
[TBL] [Abstract][Full Text] [Related]
37. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
[TBL] [Abstract][Full Text] [Related]
38. Alterations in metabolic pathways and networks in Alzheimer's disease.
Kaddurah-Daouk R; Zhu H; Sharma S; Bogdanov M; Rozen SG; Matson W; Oki NO; Motsinger-Reif AA; Churchill E; Lei Z; Appleby D; Kling MA; Trojanowski JQ; Doraiswamy PM; Arnold SE;
Transl Psychiatry; 2013 Apr; 3(4):e244. PubMed ID: 23571809
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer's disease using liquid chromatography mass spectrometry.
Rong W; Ding K; Guo S; Xie F; Li Q; Bi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121739. PubMed ID: 31430683
[TBL] [Abstract][Full Text] [Related]
40. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
